JPMorgan Chase & Co. Lowers Position in HealthEquity, Inc. (NASDAQ:HQY)

JPMorgan Chase & Co. trimmed its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 17.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,215,321 shares of the company’s stock after selling 252,244 shares during the quarter. JPMorgan Chase & Co. owned 1.40% of HealthEquity worth $99,474,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. International Assets Investment Management LLC bought a new stake in HealthEquity during the second quarter worth $35,000. Paladin Wealth LLC purchased a new stake in shares of HealthEquity during the 3rd quarter valued at $39,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of HealthEquity in the 2nd quarter worth about $73,000. GAMMA Investing LLC grew its position in HealthEquity by 57.8% during the third quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock valued at $77,000 after buying an additional 344 shares during the period. Finally, Quarry LP increased its holdings in HealthEquity by 418.8% during the third quarter. Quarry LP now owns 1,349 shares of the company’s stock worth $110,000 after buying an additional 1,089 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on HQY shares. Mizuho began coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target on the stock. Bank of America boosted their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. JMP Securities boosted their price objective on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. BTIG Research upped their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Finally, Barrington Research lifted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, HealthEquity currently has a consensus rating of “Moderate Buy” and an average price target of $110.71.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $96.81 on Friday. The stock’s 50-day simple moving average is $96.69 and its two-hundred day simple moving average is $85.38. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $105.82. The firm has a market capitalization of $8.39 billion, a P/E ratio of 88.82, a P/E/G ratio of 1.08 and a beta of 0.55. The company has a quick ratio of 4.10, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the sale, the director now owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares of the company’s stock, valued at $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 42,539 shares of company stock valued at $4,040,303 over the last three months. 2.20% of the stock is owned by corporate insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.